Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways to New Emerging Targets

Small Molecules in Parkinson’s Disease Therapy: From Dopamine Pathways to New Emerging Targets

Parkinson’s disease (PD) is a chronic, progressive neurological disorder affecting approximately 10 million people worldwide, with prevalence expected to rise as the global population ages. It is characterized by the degeneration of dopamine-producing neurons in the substantia nigra pars compacta, l...

Full description

Saved in:
Bibliographic Details
Main Authors: Hwayoung Lee, Ahmed Elkamhawy, Polina Rakhalskaya, Qili Lu, Hossam Nada, Guofeng Quan, Kyeong Lee
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Pharmaceuticals
Subjects:
Parkinson’s disease (PD)
dopamine
small molecules
Online Access:https://www.mdpi.com/1424-8247/17/12/1688
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items